Opening Keynote Session
Roy Beveridge, M.D.
James R. Downing, M.D.
Eric J. Gertler
Laurie H. Glimcher, M.D.
John W. Lin, M.D.
Kevin E. Lofton
Mitch Morris, M.D.
Peter WT Pisters, M.D.
–Brian Kelly, Editor and Chief Content Officer, U.S. News & World Report
–Eric J. Gertler, Executive Chairman, U.S. News & World Report; Chief Executive Officer, Ulysses Ventures
CHANGE AGENTS: A CONVERSATION WITH CEOS WHO ARE DOING BUSINESS DIFFERENTLY
Improving patient care and reining in costs may require radical moves in new directions: health systems tackling drug manufacturing and the consequences of poverty, employers banding together to provide better treatment and more affordable coverage, health insurers investing in clinical practices – and everybody doing a much better job of using data. Hear perspectives from the front lines.
–A. Marc Harrison, M.D., President and Chief Executive Officer, Intermountain Healthcare
–Kevin E. Lofton, Chief Executive Officer, Catholic Health Initiatives
–Mitch Morris, M.D., President, Optum Advisory Services
–Susan N. Story, President and Chief Executive Officer, American Water
-Moderator: Chas Roades, Co-Founder and Chief Executive Officer, Gist Healthcare
–Roy Beveridge, M.D., Chief Medical Officer, Humana
CUTTING-EDGE CANCER CARE: THE PROMISE AND THE REALITIES
The revelations of genomics and immunology are transforming cancer care. How well are the new treatments really working? Is the cost worth the benefit? How can community hospitals take the best care of their patients? And what do patients need to know?
–James R. Downing, M.D., President and Chief Executive Officer, St. Jude Children’s Research Hospital
–Laurie H. Glimcher, M.D., President and Chief Executive Officer, Dana-Farber Cancer Institute
–Peter WT Pisters, M.D., President, University of Texas MD Anderson Cancer Center
-Moderator: John W. Lin, M.D., Global Strategy Leader, GE Healthcare